Pharma Mar (OTCMKTS:PHMMF) Sets New 1-Year High – Here’s Why

Pharma Mar, S.A. (OTCMKTS:PHMMF) hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $75.00 and last traded at $75.00, with a volume of 0 shares changing hands. The stock had previously closed at $75.00.

Analyst Upgrades and Downgrades

Separately, Chardan Capital raised Pharma Mar to a “strong-buy” rating in a research note on Thursday, August 1st.

Pharma Mar Price Performance

The company has a debt-to-equity ratio of 0.14, a quick ratio of 2.01 and a current ratio of 2.55. The firm has a 50 day moving average price of $65.97 and a two-hundred day moving average price of $45.80.

About Pharma Mar

Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.